ArticleNaunyn-Schmiedeberg's archives of pharmacology1993
Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Inhibition by ethanol of excitatory amino acid receptors and nicotinic acetylcholine receptors at rat locus coeruleus neurons.Naunyn-Schmiedeberg's archives of pharmacology · 1994Article
- Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.British journal of pharmacology · 1994Article
- Blockade by 4,4'-diisothiocyanatostilbene-2,2'-disulphonate (DIDS) of P2X-purinoceptors in rat vas deferens.British journal of pharmacology · 1994Article
- Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.British journal of pharmacology · 1994Article
- Evans blue blocks P2X-purinoceptors in rat vas deferens.Naunyn-Schmiedeberg's archives of pharmacology · 1993Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Some ligand-gated ion channels are important sites of action of ethanol. The aim of the study was to find out whether the P2X-purinoceptors mediating contraction of the rat isolated vas deferens also are selectively sensitive to ethanol. Contractions were elicited by ATP (1 mmol/l), alpha, beta-methylene ATP (0.3 mumol/l), noradrenaline (3 mumol/l), high K+ (20 mmol/l) or electrical (neural) stimulation by pairs of pulses 3 s apart. In electrical stimulation experiments, purinergic and adrenergic response components were isolated by prazosin and suramin, respectively. Concentration-effect curves were determined for ethanol and, for comparison, nifedipine. Tritium outflow from tissues preincubated with 3H-noradrenaline was also examined. Ethanol at relatively low concentrations reduced contractions elicited by high K+ (IC30 145 mmol/l), ATP (IC30 211 mmol/l) and alpha, beta-methylene ATP (IC30 215 mmol/l) as well the purinergic component of neurogenic twitches (IC30 110-126 mmol/l; a significant effect at 10-32 mmol/l) and the adrenergic component of twitch 2 of the twitch pairs (IC30 63 mmol/l). These contractions also were very sensitive to nifedipine. Higher concentrations of ethanol were needed to reduce contractions elicited by noradrenaline (IC30 365 mmol/l) and the adrenergic component of twitch 1 of the twitch pairs (IC30 382 mmol/l), contractions that also were less sensitive to nifedipine. Ethanol 1 mol/l abolished all contractions. In contrast, concentration-effect curves for the inhibition by nifedipine of contractions evoked by ATP, alpha,beta-methylene ATP and noradrenaline (rapid phase) levelled off at 60-70% inhibition.(ABSTRACT TRUNCATED AT 250 WORDS)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.